Taiwan FDA registration 900ea6f5570adc9fff0683f5a331cc79
Baijie Youshan blood glucose test system
TW: 百捷優善血糖檢驗系統
Taiwan·Risk Class 2·Qinli Biotechnology Co., Ltd. New North Plant·Registered Aug 04, 2022 – Aug 04, 2027ActiveRegistration details
- Analysis ID
- 900ea6f5570adc9fff0683f5a331cc79
Company information
- Manufacturer
- Qinli Biotechnology Co., Ltd. New North Plant
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- GENERAL LIFE BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- This product can quantitatively detect the blood glucose concentration of fingertips, palms or forearm microvascular whole blood and venous blood. This system is suitable for home self-testing and professional detection of the patient's microvascular whole blood glucose concentration, and also suitable for professionals to detect the patient's venous blood glucose concentration.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Aug 04, 2022
- Expiry Date
- Aug 04, 2027
About this record
Access comprehensive regulatory information for Baijie Youshan blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 900ea6f5570adc9fff0683f5a331cc79 and manufactured by Qinli Biotechnology Co., Ltd. New North Plant. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices